Výsledky vyhledávání - "David G. Tubergen"

Transient Leukemia With Extreme Basophilia in a Phenotypically Normal Infant With Blast Cells Containing a Pseudodiploid Clone, 46,XY i(21)(q10)

Autor: Alvin Zipursky, David G. Tubergen, Laura L. Worth, Hilary Christensen

Publikováno v: Journal of Pediatric Hematology/Oncology. 21:63-66

Purpose: Transient leukemia and extreme basophilia occurred in a phenotypically normal newborn with expression of isochromosome (21)(q10) in the blast population. Patients and Methods: A newborn boy was found to have an elevated white blood cell coun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::485b6d81794eeefe825004e4aede6bab
https://doi.org/10.1097/00043426-199901000-00014

Zobrazit plný text záznamu

Survival after relapse in childhood acute lymphoblastic leukemia

Autor: Paul S. Gaynon, Roger P. Qu, Michael L. N. Willoughby, Peter G. Steinherz, David G. Tubergen, Rick Chappell, Michael E. Trigg

Publikováno v: Cancer. 82:1387-1395

BACKGROUND Childhood acute lymphoblastic leukemia is the single most common childhood malignancy. Despite substantial improvements in therapy, cases in which relapse occurs are still more common than newly diagnosed cases of many other childhood canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63d0a03dff450d545c2745241bed10dd
https://doi.org/10.1002/(sici)1097-0142(19980401)82:7<1387::aid-cncr24>3.0.co

Zobrazit plný text záznamu

Early response to therapy and outcome in childhood acute lymphoblastic leukemia

Autor: Gregory H. Reaman, Beverly J. Lange, Harland N. Sather, Raymond J. Hutchinson, Peter G. Steinherz, Paul S. Gaynon, James B. Nachman, Michael E. Trigg, Anish A. Desai, Bruce C. Bostrom, David G. Tubergen, Fatih M. Uckun

Publikováno v: Cancer. 80:1717-1726

BACKGROUND Early response to therapy is defined as the initial response prior to Day 28 of treatment, the conventional time of marrow evaluation. The number of reports linking early response to therapy with the ultimate outcome of childhood acute lym

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1dce09c093c02b2116a68606d7102df2
https://doi.org/10.1002/(sici)1097-0142(19971101)80:9<1717::aid-cncr4>3.0.co

Zobrazit plný text záznamu

Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group Study

Autor: Zhiwen Yang, James B. Nachman, Lisa Crotty, Fatih M. Uckun, Tamer Zeren, Gregory H. Reaman, Mireille Sarquis, Paul S. Gaynon, Bruce Bostrom, Harland N. Sather, David G. Tubergen, Peter G. Steinherz, Onur Ek

Publikováno v: Blood. 89:3769-3777

We found a marked variation in BCL-2 oncoprotein expression levels of primary leukemic cells from 338 children with newly diagnosed acute lymphoblastic leukemia (ALL). None of the high-risk features predictive of poor treatment outcome in childhood A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::781bf9de8fc09ddcacf75408b6ce8e5e
https://doi.org/10.1182/blood.v89.10.3769

Zobrazit plný text záznamu

Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors

Autor: Gerald B. Sharp, Carol A. Greenwald, Sue C. Kaste, Deborah B. Crom, Melissa M. Hudson, David G. Tubergen

Publikováno v: Medical and Pediatric Oncology. 28:15-21

We prospectively used ultrasonography to detect thyroid abnormalities in 96 long-term survivors of childhood cancer, who received head and neck radiation therapy at a median age of 8.9 years. The median time interval since irradiation was 10.8 years

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e9eb2c199a570ecf231ef0a02f420d0f
https://doi.org/10.1002/(sici)1096-911x(199701)28:1<15::aid-mpo4>3.0.co

Zobrazit plný text záznamu

The Frequency and Consequences of Varicella Exposure and Varicella Infection in Children Receiving Maintenance Therapy for Acute Lymphoblastic Leukemia

Autor: Myron J. Levin, David G. Tubergen, Kim Buda

Publikováno v: Journal of Pediatric Hematology/Oncology. 18:106-112

The frequency and cost of varicella and varicella exposure were determined in children receiving maintenance chemotherapy for acute lymphocytic leukemia, and the cost of a preventative strategy using the varicella vaccine was estimated.Retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77dbdedcab48a950115dc00eec873ae
https://doi.org/10.1097/00043426-199605000-00003

Zobrazit plný text záznamu

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

Publikováno v: Journal of Clinical Oncology. 14:18-24

PURPOSE To define more uniform criteria for risk-based treatment assignment for children with acute lymphoblastic leukemia (ALL), the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) sponsored a workshop in September 19

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e320a369b0cc617bc21c09059143d1
https://doi.org/10.1200/jco.1996.14.1.18

Zobrazit plný text záznamu

Improved Clinical Outcome for Children with T-Lineage Acute Lymphoblastic Leukemia After Contemporary Chemotherapy:A Children's Cancer Group Study

Autor: David G. Tubergen, Fatih M. Uckun, G Reaman, Harland Sather, Peter G. Steinherz, Diane C. Arthur, Michael E. Trigg, Paul S. Gaynon

Publikováno v: Leukemia & Lymphoma. 24:57-70

The prognostic importance of T-lineage acute lymphoblastic leukemia (ALL) in contemporary programs of intensive chemotherapy has been controversial. We therefore assessed the impact of this biological feature in risk-adjusted frontline chemotherapy s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3dd2c649ced610c1ed0ea036d971c8a
https://doi.org/10.3109/10428199609045714

Zobrazit plný text záznamu

Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study

Autor: John H. Kersey, Jeffrey G. Rosenstock, Marshall E. Kadin, Mark Krailo, Peter G. Steinherz, Denis R. King, David G. Tubergen, Anna T. Meadows, Margaret Morse

Publikováno v: Journal of Clinical Oncology. 13:1368-1376

PURPOSE Patients with lymphoblastic non-Hodgkin's lymphoma (LB NHL) were randomized to treatment with either modified LSA2L2 or ADCOMP, which added daunorubicin (DAUN) and asparaginase (L-ASP) to the methotrexate (MTX), cyclophosphamide (CYT), vincri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddac753ad78ef318fccc96f61abbcbb2
https://doi.org/10.1200/jco.1995.13.6.1368

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání